B Alshaikh1, W Yee2, A Lodha2, E Henderson3, K Yusuf2, R Sauve1. 1. 1] Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada [2] Department of Pediatrics, University of Calgary, Calgary, AB, Canada. 2. Department of Pediatrics, University of Calgary, Calgary, AB, Canada. 3. Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.
Abstract
OBJECTIVE: The objective of this study was to examine the impact of Coagulase-negative staphylococcus (CoNS) sepsis in preterm infants on the neurodevelopmental outcomes at 30 to 42 months corrected age (CA). STUDY DESIGN: This is a retrospective cohort study. All preterm infants born at <29 weeks gestational age between 1995 and 2008 and had a neurodevelopmetnal assessment at 30 to 42 months CA were eligible. The neurodevelopmetnal outcomes of infants exposed to CoNS sepsis were compared with infants unexposed to any type of neonatal sepsis. RESULT: A total of 105 eligible infants who were exposed to CoNS sepsis were compared with 227 infants with no neonatal sepsis. In univariate analysis, infants with CoNS sepsis were more likely to have total major disability (odds ratio (OR)=1.9; 95% CI: 1.07 to 3.38) and cognitive delay (OR=2.53; 1.26 to 5.14).There was no significant difference in the incidence of cerebral palsy, blindness and deafness between the two groups. After correcting for potential confounders, CoNS sepsis was associated with increased risk of cognitive delay (adjusted odds ratio (aOR)= 2.23; 95% CI 1.01 to 4.9), but not with the total major disability (aOR=1.14; 95% CI: 0.55 to 2.34). CONCLUSION: Our study suggests that CoNS sepsis in preterm infants might be associated with increased risk for cognitive delay at 36 months CA.
OBJECTIVE: The objective of this study was to examine the impact of Coagulase-negative staphylococcus (CoNS) sepsis in preterm infants on the neurodevelopmental outcomes at 30 to 42 months corrected age (CA). STUDY DESIGN: This is a retrospective cohort study. All preterm infants born at <29 weeks gestational age between 1995 and 2008 and had a neurodevelopmetnal assessment at 30 to 42 months CA were eligible. The neurodevelopmetnal outcomes of infants exposed to CoNS sepsis were compared with infants unexposed to any type of neonatal sepsis. RESULT: A total of 105 eligible infants who were exposed to CoNS sepsis were compared with 227 infants with no neonatal sepsis. In univariate analysis, infants with CoNS sepsis were more likely to have total major disability (odds ratio (OR)=1.9; 95% CI: 1.07 to 3.38) and cognitive delay (OR=2.53; 1.26 to 5.14).There was no significant difference in the incidence of cerebral palsy, blindness and deafness between the two groups. After correcting for potential confounders, CoNS sepsis was associated with increased risk of cognitive delay (adjusted odds ratio (aOR)= 2.23; 95% CI 1.01 to 4.9), but not with the total major disability (aOR=1.14; 95% CI: 0.55 to 2.34). CONCLUSION: Our study suggests that CoNS sepsis in preterm infants might be associated with increased risk for cognitive delay at 36 months CA.
Authors: Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas Journal: Nat Med Date: 2009-06 Impact factor: 53.440
Authors: Minesh Khashu; Horacio Osiovich; Deborah Henry; Aziz Al Khotani; Alfonso Solimano; David P Speert Journal: Pediatrics Date: 2006-02 Impact factor: 7.124
Authors: L J Woodward; S Moor; K M Hood; P R Champion; S Foster-Cohen; T E Inder; N C Austin Journal: Arch Dis Child Fetal Neonatal Ed Date: 2009-03-22 Impact factor: 5.747
Authors: Rhodri O Lloyd; John M O'Toole; Vicki Livingstone; William D Hutch; Elena Pavlidis; Anne-Marie Cronin; Eugene M Dempsey; Peter M Filan; Geraldine B Boylan Journal: Pediatr Res Date: 2016-04-18 Impact factor: 3.756
Authors: Celeste Beck; Kelly Gallagher; Leigh A Taylor; Jeffery A Goldstein; Leena B Mithal; Alison D Gernand Journal: Obstet Gynecol Date: 2021-06-01 Impact factor: 7.623
Authors: J W Logan; O Dammann; E N Allred; C Dammann; K Beam; R M Joseph; T M O'Shea; A Leviton; K C K Kuban Journal: J Perinatol Date: 2017-01-12 Impact factor: 2.521